HFS
ADMA icon

Hantz Financial Services’s ADMA Biologics ADMA Stock Holding History

Hantz Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97K Buy
11,627
+7,638
+191% +$69.6K ﹤0.01% 1397
2026
Q1 		$36K Buy
3,989
+2,904
+268% +$45.8K ﹤0.01% 1665
2025
Q4 		$20K Buy
1,085
+270
+33% +$4.55K ﹤0.01% 1783
2025
Q3 		$12K Buy
815
+467
+134% +$8.01K ﹤0.01% 1750
2025
Q2 		$6K Buy
348
+328
+1,640% +$6.69K ﹤0.01% 1665
2025
Q1 		$0 Buy
+20
New +$346 ﹤0.01% 1655

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hantz Financial Services's ADMA Position: Q2 2026 in Review

Hantz Financial Services increased its ADMA Biologics (ADMA) stake by 191% in Q2 2026, buying an estimated $69.6K and bringing the position to 11,627 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Hantz Financial Services first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Hantz Financial Services held 11,627 shares of ADMA Biologics worth $97K as of Q2 2026.
  • Hantz Financial Services bought 7,638 ADMA Biologics shares in Q2 2026, an estimated $69.6K.
  • ADMA Biologics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1397 holding.
  • Hantz Financial Services first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.